CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 1, First-in-Human, Open-Label, Dose Escalation and Cohort Expansion Study of MGD019, a Bispecific DART® Protein Binding PD-1 and CTLA-4 in Patients With Unresectable or Metastatic Neoplasms

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03761017
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:26:46.533374+00:00
Published At: 2025-03-06T00:00:00+00:00
Record Updated At: 2025-03-06
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Squamous Cell Non Small Cell Lung Cancer", "Prostate Cancer Metastatic", "Cutaneous Melanoma", "Colorectal Cancer", "Advanced Cancer", "Solid Tumor, Adult"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-03-06"
protocolSection.identificationModule.nctId: "NCT03761017"
protocolSection.identificationModule.officialTitle: "A Phase 1, First-in-Human, Open-Label, Dose Escalation and Cohort Expansion Study of MGD019, a Bispecific DART\u00ae Protein Binding PD-1 and CTLA-4 in Patients With Unresectable or Metastatic Neoplasms"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.